Search clinical trials for: Relapsing Remitting Multiple Sclerosis
Total 14357 results
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
BiogenGB Pharma Services & Consulting s.r.l.Withdrawn
-
Elan PharmaceuticalsTerminatedMultiple SclerosisUnited States, Canada
-
Elan PharmaceuticalsTerminatedMultiple Sclerosis
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
Genesis LimitedTerminatedMultiple Sclerosis, Relapsing-RemittingTrinidad and Tobago
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingTrinidad and Tobago
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenWithdrawnMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis, Relapsing-RemittingIran, Islamic Republic of
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BayerCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
Universitätsklinikum Hamburg-EppendorfCompletedMultiple Sclerosis, Relapsing-Remitting
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, United States, Canada, France, Switzerland, Ireland, Italy, Australia, Spain, Austria, Germany, Brazil, Netherlands, Poland, Russian Federation, Hungary, Slovenia, Argentina, Ukraine, Greece, Sweden, Finland, Latvia, No... and more
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Germany, Russian Federation, Spain, Poland
-
SanofiCompletedMultiple SclerosisCanada, France
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | RRMSRussian Federation, Ukraine, Czech Republic
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
EMD SeronoTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
University at BuffaloTeva Pharmaceuticals USACompletedMultiple SclerosisUnited States
-
University of AarhusAarhus University Hospital; BiogenCompletedMultiple Sclerosis (Relapsing Remitting)Denmark
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
BiogenCompleted
-
Novartis PharmaceuticalsWithdrawnRelapsing-remitting Multiple Sclerosis
-
Novartis PharmaceuticalsTerminatedDepression | Relapsing-remitting Multiple SclerosisGermany
-
Johns Hopkins UniversityBiogenWithdrawn
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Merck KGaA, Darmstadt, GermanySmerud Medical Research International AS; Merck Serono NorwayCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Norway